In our study, we aimed to investigate the differential secretory potential of leukaemic blasts from paediatric patients with ALL and AML, measured as their ability to produce the selected growth factors: G-CSF, GM-CSF, b-FGF, VEGF, and PDGF. This evidence concerns the gene CSF2 and acute lymphoblastic leukemia.